About GSK Plc 
GSK Plc
Pharmaceuticals & Biotechnology
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.
Company Coordinates 
Company Details
G S K House, 980 Great West Road , BRENTFORD None : TW8 9GS
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 10 Foreign Institutions (0.13%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Sir. Jonathan Symonds
Independent Non-Executive Chairman of the Board
Ms. Emma Walmsley
Chief Executive Officer, Executive Director
Mr. Iain Mackay
Chief Financial Officer, Executive Director
Mr. Charles Bancroft
Non-Executive Director
Mr. Marvinder Banga
Senior Non-Executive Independent Director
Dr. Vivienne Cox
Independent Non-Executive Director
Ms. Lynn Elsenhans
Non-Executive Independent Director
Revenue and Profits:
Net Sales:
7,986 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,646 Million
Pharmaceuticals & Biotechnology
GBP 74,438 Million ()
13.00
NA
265.76%
1.08
43.25%
4.61






